•  
logo
  • Home
  • Pharmaceutical R&D Services
    • Customized Stroke Models
      • Animal Modeling of Stroke
      • In Vitro Modeling of Stroke
    • Pathogenic Mechanism Analysis
      • Analysis of Ischemia-Triggered Glutamate Excitotoxicity
      • Molecular Mechanism Analysis of Oxidative Stress in Stroke
      • Analysis of Neuroinflammatory Mechanisms in Stroke
      • Molecular Mechanism Analysis of Ischemia-Reperfusion Injury
      • Cell Death Mechanism Analysis in Stroke
      • Epigenetic Mechanism Analysis in Stroke
      • Analysis of Gut Microbiota in Stroke
    • Stroke Drug Development Services
      • By Drug Modality
        • Small Molecule Drugs for Stroke
        • Neuropeptides
        • Monoclonal Antibodies for Stroke
        • Stem Cell-Based Therapies for Stroke
      • By Drug Action
        • Neuroprotective Agents Against Stroke
        • Thrombolytics for Stroke
        • Anticoagulant Drugs
        • Antiplatelet Drugs for Stroke
      • Customized Biospecimen Collection and Analysis Services
    • Drug Delivery System Development for Stroke
      • Nanoparticle-Based Drug Delivery Systems
      • Liposome-Based Drug Delivery Systems
      • Exosome-Based Drug Delivery Systems
      • Nasal Drug Delivery Systems
      • Virus-Based Gene Delivery Systems
    • Preclinical Evaluation Services
      • ADME/DMPK for Stroke Drugs
      • Drug Efficacy Testing for Stroke
      • Safety Assessment for Stroke Drugs
      • In Vitro Pharmacology for Stroke Drugs
    • Stroke Biomarker Development Services
      • Stroke-Related Protein Biomarkers
      • Stroke-Related RNA Biomarkers
      • Stroke-Related Metabolite Biomarkers
      • Stroke-Related Lipid Biomarkers
      • Stroke Biomarker Panels
  • Therapeutic Areas
    • Preclinical Ischemic Stroke Research Services
      • Thrombotic Stroke
      • Embolic Stroke
      • Cardioembolic Stroke
      • Cryptogenic Stroke
    • Preclinical Hemorrhagic Stroke Research Services
      • Intracerebral Hemorrhage
      • Subarachnoid Hemorrhage
    • Preclinical Transient Ischemic Attack Research Services
  • Virtual Booth
    • Brochures
    • Stroke Models
    • Case Studies
    • Protocols
  • Resources
    • Research Resources
    • Technical Notes
  • Company
    • Contact Us
    • About Us
    • Careers
Search

 

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Technical Notes

  1. Home
  2. Resources
  3. Technical Notes
  • Optimizing Stroke Drug Discovery: Surface Plasmon Resonance Techniques and their Applications

    Optimizing Stroke Drug Discovery: Surface Plasmon Resonance Techniques and their Applications

  • Corneal Confocal Microscopy Detects Corneal Nerve Damage in Stroke

    Corneal Confocal Microscopy Detects Corneal Nerve Damage in Stroke

  • Techniques for Visualizing Cell Death in Experimental Cerebral Stroke

    Techniques for Visualizing Cell Death in Experimental Cerebral Stroke

  • H&E Staining and Stroke

    H&E Staining and Stroke

  • Autofluorescence in Brain Tissues Affected by Stroke

    Autofluorescence in Brain Tissues Affected by Stroke

  • Antifades & Mounting Media

    Antifades & Mounting Media

  • Antifades & Mounting Media

    Methods for Monitoring Autophagy After Ischemic Stroke

 Ace Therapeutics Preclinical CRO for Stroke

Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.

Quick Links
Home Pharmaceutical R&D Services Therapeutic Areas Resources
About us Contact us Careers
Contact Us

Copyright © 2025 Ace Therapeutics. All rights reserved.